Literature DB >> 12406576

Identification and characterization of the human long form of Sox5 (L-SOX5) gene.

Toshiyuki Ikeda1, Junwei Zhang, Tokuhiro Chano, Akihiko Mabuchi, Akira Fukuda, Hiroshi Kawaguchi, Kozo Nakamura, Shiro Ikegawa.   

Abstract

The Sox (Sry-type HMG box) group of transcription factors, which is defined by a high-mobility group (HMG) DNA-binding domain, is categorized into six subfamilies. Sox5 and Sox6 belong to the group D subfamily, which is characterized by conserved N-terminal domains including a leucine-zipper, a coiled-coil domain and a Q-box. Group D Sox genes are expressed as long and short transcripts that exhibit differential expression patterns. In mouse, the long form of Sox5, L-Sox5, is co-expressed and interacts with Sox6; together, these two proteins appear to play a key role in chondrogenesis and myogenesis. In humans, however, only the short form of Sox5 has previously been identified. To gain insight into Sox5 function, we have identified and characterized human L-SOX5. The human L-SOX5 cDNA encodes a 763-amino-acid protein that is 416 residues longer than the short form and contains all of the characteristic motifs of group D Sox proteins. The predicted L-SOX5 protein shares 97% amino acid identity with its mouse counterpart and 59% identity with human SOX6. The L-SOX5 gene contains 18 exons and shows similar genomic structure to SOX6. We have identified two transcription start sites in L-SOX5 and multiple alternatively spliced mRNA variants that are distinct from the short form. Unlike the short form, which shows testis-specific expression, L-SOX5 is expressed in multiple tissues. Like SOX6, L-SOX5 shows strong expression in chondrocytes and striated muscles, indicating a likely role in human cartilage and muscle development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406576     DOI: 10.1016/s0378-1119(02)00927-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  20 in total

Review 1.  Sox6, jack of all trades: a versatile regulatory protein in vertebrate development.

Authors:  Nobuko Hagiwara
Journal:  Dev Dyn       Date:  2011-04-14       Impact factor: 3.780

2.  SOX5 interacts with YAP1 to drive malignant potential of non-small cell lung cancer cells.

Authors:  Hongbo Zou; Shuang Wang; Songtao Wang; Hong Wu; Jing Yu; Qian Chen; Wei Cui; Ye Yuan; Xianmei Wen; Jian He; Lin Chen; Ruilian Yu; Ming Zhang; Haitao Lan; Guoxiang Jin; Xia Zhang; Xiuwu Bian; Chuan Xu
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

3.  Expressions of Sox9, Sox5, and Sox13 transcription factors in mice testis during postnatal development.

Authors:  Mikella Daigle; Pauline Roumaud; Luc J Martin
Journal:  Mol Cell Biochem       Date:  2015-06-05       Impact factor: 3.396

4.  Concerted regulation of myofiber-specific gene expression and muscle performance by the transcriptional repressor Sox6.

Authors:  Daniel Quiat; Kevin A Voelker; Jimin Pei; Nick V Grishin; Robert W Grange; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-01       Impact factor: 11.205

5.  Genetic variants on chromosomes 7p31 and 12p12 are associated with abnormal atrial electrical activation in patients with early-onset lone atrial fibrillation.

Authors:  Mariam B Seifert; Morten S Olesen; Ingrid E Christophersen; Jonas B Nielsen; Jonas Carlson; Fredrik Holmqvist; Arnljot Tveit; Stig Haunsø; Jesper H Svendsen; Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-06-01       Impact factor: 1.468

6.  Expression and function of a novel isoform of Sox5 in malignant B cells.

Authors:  Shanique K E Edwards; Anand Desai; Yan Liu; Carissa R Moore; Ping Xie
Journal:  Leuk Res       Date:  2013-12-25       Impact factor: 3.156

7.  Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic features.

Authors:  Allen N Lamb; Jill A Rosenfeld; Nicholas J Neill; Michael E Talkowski; Ian Blumenthal; Santhosh Girirajan; Debra Keelean-Fuller; Zheng Fan; Jill Pouncey; Cathy Stevens; Loren Mackay-Loder; Deborah Terespolsky; Patricia I Bader; Kenneth Rosenbaum; Stephanie E Vallee; John B Moeschler; Roger Ladda; Susan Sell; Judith Martin; Shawnia Ryan; Marilyn C Jones; Rocio Moran; Amy Shealy; Suneeta Madan-Khetarpal; Juliann McConnell; Urvashi Surti; Andrée Delahaye; Bénédicte Heron-Longe; Eva Pipiras; Brigitte Benzacken; Sandrine Passemard; Alain Verloes; Bertrand Isidor; Cedric Le Caignec; Gwen M Glew; Kent E Opheim; Maria Descartes; Evan E Eichler; Cynthia C Morton; James F Gusella; Roger A Schultz; Blake C Ballif; Lisa G Shaffer
Journal:  Hum Mutat       Date:  2012-04       Impact factor: 4.878

8.  LncRNA UCC promotes epithelial-mesenchymal transition via the miR-143-3p/SOX5 axis in non-small-cell lung cancer.

Authors:  Ri Chen; Chunfan Zhang; Yuanda Cheng; Shaoqiang Wang; Hang Lin; Heng Zhang
Journal:  Lab Invest       Date:  2021-04-06       Impact factor: 5.662

9.  Transcriptional regulation of an axonemal central apparatus gene, sperm-associated antigen 6, by a SRY-related high mobility group transcription factor, S-SOX5.

Authors:  Elizabeth Anne Kiselak; Xuening Shen; Jingmei Song; David Roberto Gude; Jiannan Wang; Steven L Brody; Jerome F Strauss; Zhibing Zhang
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

10.  Silencing of the Drosophila ortholog of SOX5 leads to abnormal neuronal development and behavioral impairment.

Authors:  Airong Li; Basavaraj Hooli; Kristina Mullin; Rebecca E Tate; Adele Bubnys; Rory Kirchner; Brad Chapman; Oliver Hofmann; Winston Hide; Rudolph E Tanzi
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.